Loading...
Market
What will be the status of rapid and home testing for H5N1 in the US by June 30, 2025?
2
Resolution / Starting Odds
Widespread availability • 25%
Limited availability • 25%
No availability • 25%
Testing halted • 25%
Announcements from the CDC or FDA regarding testing availability
Story
Dr. Leana Wen Calls for FDA to Authorize H5N1 Vaccine for Vulnerable Americans Amid 66 Human Cases
Dec 29, 2024, 05:35 PM
Dr. Leana Wen, former Commissioner of the Baltimore City Health Department, is urging the Biden administration to expedite FDA authorization of the existing H5N1 bird flu vaccine and distribute approximately five million doses to vulnerable Americans before President-elect Donald Trump takes office. Wen expressed concern over a reported mutation in a Louisiana patient and noted that there are already 66 confirmed human cases, stressing that this number is likely an undercount due to insufficient testing. She emphasized the urgent need for increased testing, including rapid and home tests, particularly for farm workers, to prevent a potential pandemic. Other health experts have issued similar warnings, cautioning that the bird flu could mutate and become a major threat.
View original story
Similar markets
Yes • 50%
No • 50%
Decreased testing • 25%
Increased testing • 25%
Other significant changes • 25%
No change • 25%
Public awareness campaigns • 25%
No significant response • 25%
Emergency funding • 25%
Increased surveillance • 25%
Moderate levels of contamination • 25%
No contamination found • 25%
Low levels of contamination • 25%
High levels of contamination • 25%
11-50 cases • 25%
0-10 cases • 25%
Over 100 cases • 25%
51-100 cases • 25%
Vaccine approved • 34%
No vaccine introduced • 33%
Vaccine in development • 33%
No significant action • 25%
Public health advisory issued • 25%
Widespread vaccination campaign initiated • 25%
Travel restrictions implemented • 25%
No positive cases • 25%
Positive cases leading to public health advisories • 25%
Positive cases leading to recalls and regulatory action • 25%
Positive cases but no public health threat • 25%